A detailed history of Sequoia Financial Advisors, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Sequoia Financial Advisors, LLC holds 111,575 shares of TEVA stock, worth $1.99 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
111,575
Previous 110,749 0.75%
Holding current value
$1.99 Million
Previous $1.56 Million 16.07%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$12.78 - $17.4 $10,556 - $14,372
826 Added 0.75%
111,575 $1.81 Million
Q1 2024

Apr 30, 2024

BUY
$10.67 - $14.43 $4,385 - $5,930
411 Added 0.37%
110,749 $1.56 Million
Q4 2023

Jan 25, 2024

BUY
$8.12 - $10.63 $41,712 - $54,606
5,137 Added 4.88%
110,338 $1.15 Million
Q3 2023

Nov 08, 2023

BUY
$7.48 - $10.7 $6,185 - $8,848
827 Added 0.79%
105,201 $1.07 Million
Q2 2023

Aug 08, 2023

SELL
$7.2 - $9.47 $42,040 - $55,295
-5,839 Reduced 5.3%
104,374 $785,000
Q1 2023

Apr 24, 2023

BUY
$8.36 - $11.37 $66,570 - $90,539
7,963 Added 7.79%
110,213 $975,000
Q4 2022

Jan 17, 2023

BUY
$7.95 - $9.48 $812,887 - $969,330
102,250 New
102,250 $0
Q2 2022

Jul 22, 2022

SELL
$7.38 - $10.4 $93,652 - $131,976
-12,690 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$7.33 - $9.39 $12,556 - $16,085
1,713 Added 15.61%
12,690 $119,000
Q4 2021

Feb 11, 2022

BUY
$7.9 - $10.19 $86,718 - $111,855
10,977 New
10,977 $88,000
Q1 2021

May 14, 2021

SELL
$10.34 - $12.81 $111,640 - $138,309
-10,797 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$8.61 - $11.04 $92,962 - $119,198
10,797 New
10,797 $104,000
Q2 2020

Aug 11, 2020

SELL
$8.12 - $13.12 $113,882 - $184,008
-14,025 Closed
0 $0
Q1 2020

May 11, 2020

BUY
$6.69 - $13.45 $93,827 - $188,636
14,025 New
14,025 $126,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Sequoia Financial Advisors, LLC Portfolio

Follow Sequoia Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sequoia Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sequoia Financial Advisors, LLC with notifications on news.